Rabbit haemorrhagic disease tissue inactivated vaccine and preparation method thereof
An inactivated vaccine and tissue technology, which can be used in pharmaceutical formulations, inactivation/attenuation, medical preparations containing active ingredients, etc. Antibody production and enhancement of leukocyte phagocytic ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0023] The rabbit plague tissue inactivated vaccine of this embodiment contains rabbit plague tissue virus liquid and propolis adjuvant, and the addition ratio is: 10 mg of propolis is contained in each milliliter of virus extract.
Embodiment 3
[0025] The rabbit plague tissue inactivated vaccine of this embodiment contains rabbit plague tissue virus liquid and propolis adjuvant, and the addition ratio is: 5 mg of propolis is contained in each milliliter of virus extract.
[0026] Preparation method embodiment of rabbit plague tissue inactivated vaccine
[0027] The preparation method of the rabbit plague tissue inactivated vaccine of the present embodiment is as follows:
[0028] 1) Treatment of diseased materials: autopsy dead rabbits with typical symptoms of rabbit plague, aseptically take more than half of the liver and add sterile saline at a ratio of 1:5, plus penicillin and streptomycin 1000U (ug) / ml, and place for 4 Centrifuge at 4000rpm / min for 5 minutes, freeze and thaw 3 times at 10000rpm / min for 5 minutes, take the supernatant and purify it by centrifugation at 10000rpm / min for 30 minutes at 4℃, and store the supernatant aseptically for later use.
[0029] 2) Rabbit subculture: 1ml / mouse of the above-ment...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 